NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDBortezomib Velcade® Malignant disease and immunosuppression, Bortezomib, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Bortezomib Bortezomib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Proteasome Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA 228: Bortezomib and thalidomide for the first-line treatment of multiple myeloma
NICE TA129: Multiple myeloma - bortezomib
NICE TA228: Bortezomib and thalidomide for the first-line treatment of multiple myeloma
NICE TA311: Multiple myeloma - bortezomib (induction therapy
NICE TA370: Bortezomib for previously untreated mantle cell lymphoma
NICE TA427: Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib
NICE TA573 Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (replaced by NICE TA897)
NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib
NICE TA897: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma
NICE TA974: Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma